期刊文献+

连续性肾脏替代疗法治疗危重病患者27例疗效分析 被引量:1

原文传递
导出
摘要 目的 探讨连续性肾脏替代疗法(CRRT)对危重病患者的疗效.方法 回顾性分析27例采用CRRT治疗的危重病患者的临床资料,对患者治疗前后肾功能、电解质、血气等指标进行比较,分析其疗效及相关影响因素.结果 本组患者在CRRT治疗后总有效率为40.7%(11/27).肾功能及血钾均较治疗前明显改善,差异有统计学意义(P〈0.05),同时血钠、血氯及凝血功能、血小板等差异无统计学意义(P〉0.05).急性肾功能不全或合并2个脏器功能不全者多数预后较好,合并3个或3个以上脏器功能不全者的疗效相对较差.结论 CRRT可用于多种危重病的救治,其毒素清除能力强,能维持内环境稳定,其疗效与原发病、脏器功能不全及治疗时机等多种因素相关.
出处 《中国医师进修杂志》 2010年第19期27-29,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献6

  • 1陶静,季大玺,龚德华,徐斌,任冰,刘芸,刘志红,黎磊石.连续性静脉-静脉血液滤过治疗八十岁以上老年多器官功能衰竭患者的经验[J].肾脏病与透析肾移植杂志,2005,14(3):208-212. 被引量:25
  • 2Luckraz H,Gravenor MB,George R,et al.Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass.Eur J Cardiothorac Surg,2005,27(5):906-909. 被引量:1
  • 3Gasparovic V,Filipovic-Grcic I,Merkler M,et al.Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD)--what is the procedure of choice in critically ill patients?Ren Fail,2003,25 (5):855-862. 被引量:1
  • 4Morabito S,Guzzo I,Solazzo A,et al.Continuous renal replacement therapies:anticoagulation in the critically ill at high risk of bleeding.J Nephrol,2003,16(4):566-571. 被引量:1
  • 5Bartholomew JR,Begelman SM,Almahameed A.Heparin-induced thrombocytopenia:principles for early recognition and management.Cleve Clin J Med,2005,72 Suppl 1:S31-36. 被引量:1
  • 6Manns B,Doig C J,Lee H,et al.Cost of acute renal failure requiring dialysis in the intensive care unit:clinical and resource implications of renal recovery.Crit Care Med,2003,31(2):449-456. 被引量:1

二级参考文献15

  • 1王士雯.老年人多器官功能衰竭若干问题[J].中华老年医学杂志,1993,12(3):182-185. 被引量:37
  • 2于剑扉,王士雯,李求是.MOFE患者血浆中IL-1、IL-6、TNF水平的变化[J].中华老年医学杂志,1995,14(2):114-114. 被引量:7
  • 3Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz ,1995 ,3 :760 - 767. 被引量:1
  • 4Silvester W, Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the critically ill. In:C. Ronco, R. Bellomo, eds. Critical Care Nephrology. Dordrecht: Kluwer Academic Publishers, 1998,1225 - 1238. 被引量:1
  • 5Schetz M, Ferdinande P, Van der Berghe G, et al. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med, 1995,21 : 169 - 176. 被引量:1
  • 6Van Bommel EF, Hesse CJ, Jutte NH, et al. Cytokine kinetics(TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration:a laboratory and clinical study. Contrib Nephrol, 1995,116:62 - 75. 被引量:1
  • 7Ronco C, Tetta C, Lupi A, et al. Removal for plateletactivating factor in experimental continuous arteriovenous hemofltration. Crit Care Med, 1995,23:99 - 107. 被引量:1
  • 8Cole L, Bellomo R, Journois D,et al. Tipping p: High-volume haemofiltration in human septic shock. Intensive Care Med, 2001,27(6):978 -986. 被引量:1
  • 9Bellomo R, Boyce N. Continuous veno-venous hemofiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J, 1993,39:794. 被引量:1
  • 10Van Bommel EFH, Bouvy ND, So KL, et al. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol, 1995,15 : 192. 被引量:1

共引文献24

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部